drugset / Trial / NCT00329589
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase 1
Completed
54 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Millennium Pharmaceuticals, Inc. · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety of Velcade when used with chemoradiation in cancer patients.
Timeline
- Start
- 2005-09
- Primary completion
- 2010-06
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | — | Intravenous |